The pathogenicity scoring system for mitochondrial tRNA mutations revisited. Issue 2 (11th November 2013)

• Record Type: Journal Article
• Authors: González‐Vioque, Emiliano; Bornstein, Belén; Gallardo, María Esther; Fernández‐Moreno, Miguel Ángel; Garesse, Rafael
• Is Part Of: Molecular genetics & genomic medicine. Volume 2:Issue 2(2014:Mar.)
• Page Start: 107
• Page End: 114
• Publication Date: 2013-11-11
• Subjects: Medical genetics -- Periodicals; Genomics -- Periodicals; 616.042
• DOI: 10.1002/mgg3.47
• Languages: English
• ISSNs: 2324-9269

Abstract

<abstract abstract-type="main" id="mgg347-abs-0001"> <title>Abstract</title> <p>Confirming the pathogenicity of mitochondrial tRNA point mutations is one of the classical challenges in the field of mitochondrial medicine. In addition to genetic and functional studies, the evaluation of a genetic change using a pathogenicity scoring system is extremely useful to discriminate between disease‐causing mutations from neutral polymorphisms. The pathogenicity scoring system is very robust for confirming pathogenicity, especially of mutations that show impaired activity in functional studies. However, mutations giving normal results using the same functional approaches are disregarded, and this compromises the power of the system to rule out pathogenicity. We propose to include a new criterion in the pathogenicity scoring systems regarding mutations which fail to show any mitochondrial defect in functional studies. To evaluate this proposal we characterized two mutations, m.8296A>G and m.8347A>G, in the mitochondrial tRNA<sup>L</sup><sup>ys</sup> gene (<italic>MT‐TK</italic>) using <italic>trans</italic>‐mitochondrial cybrid analysis. m.8347A>G mutation severely impairs oxidative phosphorylation, suggesting that it is highly pathogenic. By contrast, the behavior of cybrids homoplasmic for the m.8296A>G mutation is similar to cybrids containing wild‐type mitochondrial DNA (mtDNA). The results indicate that including not only positive but also negative outcomes of functional studies in the scoring system is critical for facilitating the diagnosis of this complex group of diseases.</p> </abstract>